Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome

Journal of Neuroimmunology

Volumn 170, Issue 1-2, 2005, Pages 150-157

  Korfei, Martina ^a   Fühlhuber, Verena ^a   Schmidt Wöll, Thomas ^a   Kaps, Manfred ^a   Preissner, Klaus T ^a   Blaes, Franz ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Antineuronal autoantibodies; Antitumor immunity; Childhood; Flow cytometry; Paraneoplastic neurological syndrome

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ANTIGEN BINDING; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MYOCLONUS; NEUROBLASTOMA; OPSOCLONUS; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN BINDING;

APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; NEUROBLASTOMA; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM;

EID: 28444462892     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.08.018     Document Type: Article

References (35)

1. G. Adamus, M. Machnicki, and G.M. Seigel Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy Invest. Ophthalmol. Visual Sci. 38 1997 283 291
2. D. Alarcon-Segovia, A. Ruiz-Arguelles, and L. Llorente Broken dogma: penetration of autoantibodies into living cells Immunol. Today 17 1996 163 164
3. M.L. Albert, J.C. Darnell, A. Bender, L.M. Francisco, N. Bhardwaj, and R.B. Darnell Tumor-specific killer cells in paraneoplastic cerebellar degeneration Nat. Med. 4 1998 1321 1324
4. A.J. Altman, and R.L. Baehner Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma Cancer 37 1976 846 852
5. N.E. Anderson, C. Budde-Steffen, M.K. Rosenblum, F. Graus, D. Ford, B.J. Synek, and J.B. Posner Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome Medicine (Baltimore) 67 1988 100 109
6. N.L. Antunes, Y. Khakoo, K.K. Matthay, R.C. Seeger, D.O. Stram, E. Gerstner, L.E. Abrey, and J. Dalmau Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus J. Pediatr. Hematol./Oncol. 22 2000 315 320
7. L. Bataller, F. Graus, A. Saiz, and J.J. Vilchez Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus Brain 124 2001 437 443
8. L. Bataller, M.R. Rosenfeld, F. Graus, J.J. Vilchez, N.K. Cheung, and J. Dalmau Autoantigen diversity in the opsoclonus-myoclonus syndrome Ann. Neurol. 53 2003 347 353
9. B. Benyahia, R. Liblau, H. Merle-Beral, J.M. Tourani, J. Dalmau, and J.Y. Delattre Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies Ann. Neurol. 45 1999 162 167
10. F. Blaes, D. Beeson, P. Plested, B. Lang, and A. Vincent IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor Ann. Neurol. 47 2000 504 510
11. D.B. Braxton, M. Williams, D. Kamali, S. Chin, R. Liem, and N. Latov Specificity of human anti-neurofilament autoantibodies J. Neuroimmunol. 21 1989 193 203
12. R.J. Buckanovich, Y.Y. Yang, and R.B. Darnell The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies J. Neurosci. 16 1996 1114 1122
13. A.M. Connolly, A. Pestronk, S. Mehta, M.R. Pranzatelli III, and M.J. Noetzel Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues J. Pediatr. 130 1997 878 884
14. R. Cooper, Y. Khakoo, K.K. Matthay, J.N. Lukens, R.C. Seeger, D.O. Stram, R.B. Gerbing, A. Nakagawa, and H. Shimada Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group Med. Pediatr. Oncol. 36 2001 623 629
15. R.C. Dale Childhood opsoclonus myoclonus Lancet Neurol. 2 2003 270
16. J. Dalmau, H.M. Furneaux, M.K. Rosenblum, F. Graus, and J.B. Posner Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy Neurology 41 1991 1757 1764
17. R. De Giorgio, M. Bovara, G. Barbara, M. Canossa, G. Sarnelli, F. De Ponti, V. Stanghellini, M. Tonini, S. Cappello, E. Pagnotta, E. Nobile-Orazio, and R. Corinaldesi Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility Gastroenterology 125 2003 70 79
18. J.E. Greenlee, T.N. Parks, and K.A. Jaeckle Type IIa ('anti-Hu') antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro Neurology 43 1993 2049 2054
19. K.C. Kuban, M.A. Ephros, R.L. Freeman, L.B. Laffell, and M.J. Bresnan Syndrome of opsoclonus-myoclonus caused by Coxsackie B3 infection Ann. Neurol. 13 1983 69 71
20. O. Lily, J. Palace, and A. Vincent Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study Brain 127 2004 269 279
21. F.A. Luque, H.M. Furneaux, R. Ferziger, M.K. Rosenblum, S.H. Wray, S.C. Schold Jr., M.J. Glantz, K.A. Jaeckle, H. Biran, and M. Lesser Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer Ann. Neurol. 29 1991 241 251
22. J. Newsom-Davis Lambert-Eaton myasthenic syndrome Rev. Neurol. (Paris) 160 2004 177 180
23. H. Nishihira, Y. Toyoda, Y. Tanaka, R. Ijiri, N. Aida, M. Takeuchi, K. Ohnuma, H. Kigasawa, K. Kato, and T. Nishi Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution J. Clin. Oncol. 18 2000 3012 3017
24. M.J. Noetzel, L.P. Cawley, V.L. James, B.J. Minard, and H.C. Agrawal Anti-neurofilament protein antibodies in opsoclonus-myoclonus J. Neuroimmunol. 15 1987 137 145
25. A. Pinto, S. Gillard, F. Moss, K. Whyte, P. Brust, M. Williams, K. Stauderman, M. Harpold, B. Lang, J. Newsom-Davis, D. Bleakman, D. Lodge, and J. Boot Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons Proc. Natl. Acad. Sci. U. S. A. 95 1998 8328 8333
26. M.R. Pranzatelli The immunopharmacology of the opsoclonus-myoclonus syndrome Clin. Neuropharmacol. 19 1996 1 47
27. M.R. Pranzatelli, E.D. Tate, A. Wheeler, N. Bass, A.P. Gold, M.L. Griebel, M. Gumbinas, P.T. Heydemann, P.J. Holt, P. Jacob, S. Kotagal, C.J. Minarcik, and H.S. Schub Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia Pediatr. Neurol. 27 2002 384 387
28. M.R. Pranzatelli, A.L. Travelstead, E.D. Tate, T.J. Allison, E.J. Moticka, D.N. Franz, M.A. Nigro, J.T. Parke, D.A. Stumpf, and S.J. Verhulst B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes Neurology 62 2004 1526 1532
29. M.R. Pranzatelli, A.L. Travelstead, E.D. Tate, T.J. Allison, and S.J. Verhulst CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity Mov. Disord. 19 2004 770 777
30. M. Reichlin Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins J. Autoimmun. 11 1998 557 561
31. K.H. Schafer, M. Klotz, D. Mergner, P. Mestres, K. Schimrigk, and F. Blaes IgG-mediated cytotoxicity to myenteric plexus cultures in patients with paraneoplastic neurological syndromes J. Autoimmun. 15 2000 479 484
32. M. Tanaka, K. Tanaka, S. Tokiguchi, K. Shinozawa, and S. Tsuji Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody J. Neurol. Sci. 168 1999 28 31
33. J.J. Verschuuren, J. Dalmau, R. Hoard, and J.B. Posner Paraneoplastic anti-Hu serum: studies on human tumor cell lines J. Neuroimmunol. 79 1997 202 210
34. K. Yanase, R.M. Smith, A. Puccetti, L. Jarett, and M.P. Madaio Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1 J. Clin. Invest. 100 1997 25 31
35. Y.Y. Yang, G.L. Yin, and R.B. Darnell The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia Proc. Natl. Acad. Sci. U. S. A. 95 1998 13254 13259